AKTX
Akari Therapeutics
AKTX
AKTX
21 hedge funds and large institutions have $56M invested in Akari Therapeutics in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
+2
Holders Change %
+10.53%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
4
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$6.1M |
2 |
BBA
Baker Bros. Advisors
New York
|
+$1.36M |
3 |
UBS Group
Zurich,
Switzerland
|
+$321K |
4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$200K |
5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$8.58K |